Table 1.
AGA | Patients with esophagitis who are intolerant of PPI therapy |
Patients with symptoms of the esophageal GERD syndrome poorly controlled by PPI therapy, especially in the setting of persistent troublesome regurgitation | |
Carefully selected patients with extraesophageal GERD syndromes in whom a reflux causality has been established to the greatest degree possible | |
SAGES | Patients who have failed medical management (inadequate symptom control, severe regurgitation not controlled with acid suppression, or medication side-effects) |
Patients who opt for surgery despite successful medical management | |
Patients who have complications of GERD (e.g., Barrett’s esophagus, peptic stricture) | |
Patients who have extra-esophageal manifestations (asthma, hoarseness, cough, chest pain, aspiration) | |
ACG | Surgical therapy is a treatment option for long-term therapy in GERD patients |
Surgical therapy is generally not recommended in patients who do not respond to PPI therapy | |
Refractory patients with objective evidence of ongoing reflux as the cause of symptoms should be considered for additional antireflux therapies, which may include surgery | |
Surgery should generally not be performed to treat extraesophageal symptoms of GERD in patients who do not respond to acid suppression with a PPI |
PPI: Proton pump inhibitor; GERD: Gastroesophageal reflux disease; AGA: American Gastroenterological Association; SAGES: Society of Gastrointestinal and Endoscopic Surgeons; ACG: American College of Gastroenterology.